| 1 |
In the case of infants born to HBsAg positive mothers a three-dose primary course of HepB vaccination is given at birth (up to 24 hours after birth), at 3-5 weeks and at 5-9 months. |
| 2 |
Given in a combined form as DTaP-IPV-Hib-HepB (hexavalent vaccine). |
| 3 |
Compulsory vaccination simultaneously administered with hexavalent vaccine. |
| 4 |
Given in a combined form as DTaP-IPV. |
| 5 |
Recommended only for those known to be tuberculin negative. |
| 6 |
Given in a combined form as dT-IPV (trivalent vaccine). |
| 7 |
Given to adults as a booster dose every 15 years after the previous vaccination. |
|
Historic changes
Measles, mumps and rubella:
1969: Measles vaccine introduced into national childhood vaccination schedule for children aged 12 months.
1974: Age for measles vaccination changed to 9 months.
1977: Second dose of measles vaccine was introduced to 11 - 15 months old children.
1982: Age of measles vaccination changed to 11 months for the first dose and to 18 - 22 months for the second dose. Rubella vaccination was introduced for 11 year- old seronegative girls.
1984: Rubella vaccination was introduced for all 11 years old girls.
1985: Age of measles vaccination changed to 14 months for the first dose and to 20 - 24 months for the second dose. Rubella vaccination was introduced for all 2 years old children.
1987: Combined mumps and measles vaccine introduced into national childhood vaccination schedule at 14 months (first dose) and 20-24 months (second dose).
1990: Second dose vaccination against mumps and measles changed to 13 years.
1992: Combined vaccine against measles, mumps and rubella was introduced into national childhood vaccination in schedule 14 months (first dose) and 13 years (second dose).
1995: Age of second MMR dose changed to 11 years.
Hepatitis B:
1998: HepB introduced.
2004: HepB is given at 10 years of age.
2008: Vaccination completed in ex-adolescents.
Haemophilus influenza type b:
2000: Hib introduced.
Poliomyelitis:
2005: IPV replaced OPV.
Diphtheria and tetanus:
2004: Booster dose of Td introduced for children 12 years of age.
2009: Booster dose introduced for adults every 15 years after the previous vaccination.
Pneumococcal vaccine:
2008: April. PCV7 universally recommended to children less than 2 years old as complementary (optional) vaccination for optimal individual protection. Cost of vaccine is shared with 96% of cost reimbursed by the national health insurance. However, it is free of charge to children less than 2 years old belonging to risk groups.
2009: January. PCV7 implemented into the national vaccination schedule as compulsory being fully reimbursed by the national health insurance. |
This summary chart is adapted from the national immunisation schedule of the Slovak Republic and ordered by the Chief Hygienist of the Slovak Republic and Ministry of Health of the Slovak Republic. The schedule may be accessed through the the webpage of Public Health Authority of the Slovak Republic www.uvzsr.sk (in Slovak and in English). |